1.34
price up icon6.35%   +0.08
pre-market  プレマーケット:  1.34  
loading

TRACON Pharmaceuticals Inc (TCON) 最新ニュース

TCON’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle

pulisher
The InvestChronicle

TCON’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle

pulisher
The InvestChronicle

Market Momentum: TRACON Pharmaceuticals Inc (TCON) Registers a -7.42 Decrease, Closing at 1.00 – DWinneX - The Dwinnex

pulisher
The Dwinnex

TRACON Pharmaceuticals (NASDAQ:TCON) Upgraded to Buy at StockNews.com - Defense World

pulisher
Defense World

TRACON Pharmaceuticals Revs Up for Growth - All Finance Times

pulisher
All Finance Times

How will TRACON Pharmaceuticals Inc's (TCON) earnings compare to estimates this quarter? – US Post News - US Post News

pulisher
US Post News

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Short Interest Down 18.9% in May - Defense World

pulisher
Defense World

In the Green: TRACON Pharmaceuticals Inc (TCON) Closes at 1.25, Up/Down -17.22 from Previous Day – DWinneX - The Dwinnex

pulisher
The Dwinnex

TRACON Pharmaceuticals (NASDAQ:TCON) Stock Price Passes Below 50 Day Moving Average of $3.55 - Defense World

pulisher
Defense World

Tracon: 2Q Earnings Snapshot - Yahoo News UK

pulisher
Yahoo News UK

TRACON Pharmaceuticals (NASDAQ:TCON) Rating Lowered to Hold at StockNews.com - Defense World

pulisher
Defense World

TRACON Pharmaceuticals (NASDAQ:TCON) Rating Lowered to Hold at StockNews.com - Defense World

pulisher
Defense World

David Lazar Joins TRACON Pharmaceuticals as Chief Business Officer - TipRanks.com - TipRanks

pulisher
TipRanks

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q1 2024 Earnings Call Transcript - Insider Monkey

pulisher
Insider Monkey

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q1 2024 Earnings Call Transcript - Insider Monkey

pulisher
Insider Monkey

TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

pulisher
GlobeNewswire

TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance

pulisher
Yahoo Finance

TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance

pulisher
Yahoo Finance

David Lazar Joins TRACON Pharmaceuticals as Chief Business Officer - TipRanks.com - TipRanks

pulisher
TipRanks

TRACON Pharmaceuticals (NASDAQ:TCON) Stock Rating Lowered by StockNews.com - Defense World

pulisher
Defense World

TRACON Pharmaceuticals (NASDAQ:TCON) Stock Rating Lowered by StockNews.com - Defense World

pulisher
Defense World

TRACON Pharmaceuticals (TCON) to Release Earnings on Tuesday - Defense World

pulisher
Defense World

Shareholders Should Check The Ownership Structure Of TRACON Pharmaceuticals Inc (NASDAQ:TCON) - Yahoo Movies Canada

pulisher
Yahoo Movies Canada

TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024 - Yahoo Canada Finance

pulisher
Yahoo Canada Finance

TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024 - Yahoo Finance

pulisher
Yahoo Finance

TRACON Pharmaceuticals (NASDAQ:TCON) Stock Price Crosses Below Two Hundred Day Moving Average of $4.04 - Defense World

pulisher
Defense World

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

pulisher
Benzinga

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day ... - Markets Insider

pulisher
Markets Insider

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

pulisher
Benzinga

Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Markets Insider

pulisher
Markets Insider

UTHR: 3 Promising Biotech Stocks Driving Weekly Gains - StockNews.com

pulisher
StockNews.com

Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024 - InvestorPlace

pulisher
InvestorPlace

Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024 - InvestorPlace

pulisher
InvestorPlace

Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session

pulisher
Benzinga

TRACON Pharmaceuticals Announces Reverse Stock Split

pulisher
GlobeNewswire Inc.

TRACON Pharmaceuticals Announces Reverse Stock Split - GlobeNewswire

pulisher
GlobeNewswire

Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

pulisher
Benzinga

TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent ... - Yahoo Finance

pulisher
Yahoo Finance

Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Markets Insider

pulisher
Markets Insider

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

pulisher
Benzinga

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid ... - Markets Insider

pulisher
Markets Insider

StockNews.com Begins Coverage on TRACON Pharmaceuticals (NASDAQ:TCON) - American Banking and Market News

pulisher
American Banking and Market News

Biotech Alert: Searches spiking for these stocks today - TipRanks.com - TipRanks

pulisher
TipRanks

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q4 2023 Earnings Call Transcript - Yahoo Finance

pulisher
Yahoo Finance

Earnings call: TRACON reports positive phase II trial data, eyes future growth By Investing.com - Investing.com

pulisher
Investing.com

TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

pulisher
GlobeNewswire Inc.

TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update - Yahoo Finance

pulisher
Yahoo Finance

TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024

pulisher
GlobeNewswire Inc.
$85.02
price up icon 1.81%
$25.78
price down icon 1.57%
$159.38
price down icon 1.97%
$157.30
price down icon 1.93%
$88.44
price down icon 3.95%
$378.30
price down icon 2.25%
大文字化:     |  ボリューム (24 時間):